Concepedia

William Hind

WH

Statistics

Publications

10

Citations

587

H-Index

10

Active since

2015

Affiliations

GW Pharmaceuticals (United Kingdom)(Current)

University of Nottingham

Royal Derby Hospital

Hospital Universitario Puerta de Hierro Majadahonda

Trinity College Dublin

William Hind is an author at GW Pharmaceuticals (United Kingdom) specializing in pharmacology, neuropharmacology, and medicine.

Publications per year

2015–2022

10

Publications

10

Cannabidiol protects an <i>in vitro</i> model of the blood–brain barrier from oxygen‐glucose deprivation via PPARγ and 5‐HT<sub>1A</sub> receptors

William Hind, Timothy J. England, Saoirse E. O’Sullivan · British Journal of Pharmacology · 2015 · 145 citations · Full text

, , +17

Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB<sub>1</sub>activation

Christopher P. Stanley, William Hind, Cristina Tufarelli et al. · Cardiovascular Research · 2015 · 98 citations · Full text

, , +6

Endocannabinoids modulate human blood–brain barrier permeability <i>in vitro</i>

William Hind, Cristina Tufarelli, Maria Neophytou et al. · British Journal of Pharmacology · 2015 · 97 citations · Full text

, , +17

MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages

John-Mark Fitzpatrick, Eleanor Minogue, Lucy Curham et al. · Journal of Neuroimmunology · 2020 · 63 citations

, , +13

Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage

Lorena Barata, Luis Arruza, Maria-José Rodríguez et al. · Neuropharmacology · 2018 · 53 citations

, , +13

1–5 of 10